Corrigendum: Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies

[This corrects the article DOI: 10.3389/fimmu.2023.1272055.].

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1407085
Main Authors Noe, Paul, Wang, Joy H, Chung, Kyu, Cheng, Zhiyong, Field, Jessica J, Shen, Xiaomeng, Casey, Stephanie C, Cortesio, Christa L, Pastuskovas, Cinthia V, Phee, Hyewon, Tarbell, Kristin V, Egen, Jackson G, Casbon, Amy-Jo
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 24.06.2024
Subjects
antibody IFN fusion
conventional type I DCs
dendritic cells
immunogenicity
Immunology
immunotherapy
interferon
antibody IFN fusion
dendritic cells
immunotherapy
pharmacokinetics
interferon
conventional type I DCs
immunogenicity
Online AccessGet full text

Cover

More Information
Summary:[This corrects the article DOI: 10.3389/fimmu.2023.1272055.].
Bibliography:corrigendum
Edited and Reviewed by: Stephen Thomas Ferris, Saint Louis University, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1407085